Your search for non small cell lung cancer returned 19 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Steve Duffy remove
Older than 2 years remove
Home remove

Your search for non small cell lung cancer returned 19 results

Sort Results:

Relevant Recent

Rituxan Gains Expanded Approval in Peds

Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are rare diseases that are generally specific to the lungs, kidneys and upper airways.

Opdivo Approved to Treat Metastatic Small Cell Lung Cancer

Data showed that 12% responded to treatment based on assessment by a Blinded Independent Central Review, regardless of PD-L1 expression; 11% had a partial response, and 1 patient had a complete response (0.9%).
Drugs in the Pipeline

Positive Top-Line Results for Ramucirumab in HCC Announced

REACH-2 was a randomized, double-blind, placebo-controlled trial that enrolled 292 patients with hepatocellular carcinoma (HCC) who were intolerant to, or had disease progression while on or following treatment with sorafenib and had a high alpha-fetoprotein (AFP-High) defined as AFP ≥400ng/mL.

First Biosimilar For Cancer Treatment Approved

The approval was based on evidence from animal study data, human pharmacokinetic and pharmacodynamics data, and clinical immunogenicity data which demonstrated Mvasi is a biosimilar to Avastin.